Skip to main content

New drugs hold promise for Alzheimer’s disease

New drugs that so far have slowed the pace of memory loss in patients with Alzheimer’s could be in the marketplace within five years, if more testing bears similar results.

Republish
Lead image for this article

New drugs that so far have slowed the pace of memory loss in patients with Alzheimer’s could be in the marketplace within five years, if more testing bears similar results. (CNBC)

Texans need truth. Help us report it.

Independent Texas reporting needs your support. The Texas Tribune delivers fact-based journalism for Texans, by Texans — and our community of members, the readers who donate, make our work possible. Help us bring you and millions of others in-depth news and information. Will you support our nonprofit newsroom with a donation of any amount?

Support independent Texas news

Become a member. Join today.

Choose an amount or learn more about membership.

$18 $20 $25 Other
Donate now

Information about the authors

Sarah Schroeder’s staff photo

Learn about The Texas Tribune’s policies, including our partnership with The Trust Project to increase transparency in news.

Explore related story topics